Ashley P Kennedy1, David H Epstein, Karran A Phillips, Kenzie L Preston. 1. Treatment Section, Clinical Pharmacology and Therapeutics Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health & Human Services, Baltimore, MD 21224, United States.
Abstract
BACKGROUND: Studies of sex differences have shown that men and women with drug-use disorders differ in course and outcome and in cue-induced activation of putative brain "control network" areas. We evaluated sex differences in daily functioning and subjective events related to drug use with ecological momentary assessment (EMA). METHODS: EMA data were collected from cocaine- and heroin-using outpatients (72 men; 42 women) in methadone maintenance in 2-5 randomly prompted (RP) entries per day and in participant-initiated entries for heroin or cocaine use or craving, for up to 25 weeks. Urine drug screens were conducted three times weekly. Data were analyzed via repeated-measures logistic regression, using sex as a predictor of responses. RESULTS: In RP reports, women and men reported significantly different patterns of drug-cue exposure, with women significantly more likely to report having seen cocaine or been tempted to use in the past hour. Women also had higher craving after past-hour exposure to drug cues. In reports of drug use, women, compared to men, were more likely to report that they had used more cocaine than they had meant to, tended to feel guilty more often after drug use, and to have used despite trying not to use. CONCLUSIONS: These findings provide real-time behavioral evidence that women respond differently than men to exposure to drug cues and to drug use, consistent with laboratory and brain-imaging findings. This information may be useful for development of sex-specific treatment strategies. Published by Elsevier Ireland Ltd.
BACKGROUND: Studies of sex differences have shown that men and women with drug-use disorders differ in course and outcome and in cue-induced activation of putative brain "control network" areas. We evaluated sex differences in daily functioning and subjective events related to drug use with ecological momentary assessment (EMA). METHODS: EMA data were collected from cocaine- and heroin-using outpatients (72 men; 42 women) in methadone maintenance in 2-5 randomly prompted (RP) entries per day and in participant-initiated entries for heroin or cocaine use or craving, for up to 25 weeks. Urine drug screens were conducted three times weekly. Data were analyzed via repeated-measures logistic regression, using sex as a predictor of responses. RESULTS: In RP reports, women and men reported significantly different patterns of drug-cue exposure, with women significantly more likely to report having seen cocaine or been tempted to use in the past hour. Women also had higher craving after past-hour exposure to drug cues. In reports of drug use, women, compared to men, were more likely to report that they had used more cocaine than they had meant to, tended to feel guilty more often after drug use, and to have used despite trying not to use. CONCLUSIONS: These findings provide real-time behavioral evidence that women respond differently than men to exposure to drug cues and to drug use, consistent with laboratory and brain-imaging findings. This information may be useful for development of sex-specific treatment strategies. Published by Elsevier Ireland Ltd.
Entities:
Keywords:
Cocaine; Craving; Drug cues; Ecological momentary assessment; Gender; Heroin; Methadone treatment; Sex differences
Authors: K A Matthews; K Räikkönen; S A Everson; J D Flory; C A Marco; J F Owens; C E Lloyd Journal: Psychosom Med Date: 2000 May-Jun Impact factor: 4.312
Authors: Kenzie L Preston; Massoud Vahabzadeh; John Schmittner; Jia-Ling Lin; David A Gorelick; David H Epstein Journal: Psychopharmacology (Berl) Date: 2009-09-24 Impact factor: 4.530
Authors: Nora D Volkow; Dardo Tomasi; Gene-Jack Wang; Joanna S Fowler; Frank Telang; Rita Z Goldstein; Nelly Alia-Klein; Christopher Wong Journal: PLoS One Date: 2011-02-23 Impact factor: 3.240
Authors: David H Epstein; Matthew Tyburski; William J Kowalczyk; Albert J Burgess-Hull; Karran A Phillips; Brenda L Curtis; Kenzie L Preston Journal: NPJ Digit Med Date: 2020-03-04
Authors: Jillian E Halladay; Michael H Boyle; Catharine Munn; Susan M Jack; Katholiki Georgiades Journal: Can J Psychiatry Date: 2018-09-27 Impact factor: 4.356